Q4

Indo Us Bio-Tech Ltd

INDOUSFY2629 May 2026

Revenue+14.2%

Net Profit-34.2%

OPM12.40%

P&L

Quarterly Standalone

Revenue

+14.2%26.02

Expenditure

+20.5%23.67

Net Profit

-34.2%1.97

NPM 7.57%-42.4%EPS ₹0.98-34.2%

vs Q3 FY26

Informational and educational content only. Not investment advice.